Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma
NCT05075460
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
107
Enrollment
OTHER
Sponsor class
Conditions
T-cell Lymphoma
Interventions
DRUG:
Tucidinostat, Azacitidine combined with CHOP
Sponsor
Peking Union Medical College Hospital